Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Paolo, Fava"'
Autor:
Paolo Fava, Gabriele Roccuzzo, Nicole Macagno, Francesco Cavallo, Valentina Celoria, Gianluca Avallone, Elisa Zavattaro, Federica Veronese, Luigi Biancone, Paola Savoia, Pietro Quaglino
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 5, Pp 1447-1453 (2024)
Abstract Background Solid organ transplant recipients (SOTRs) have an increased risk of developing non melanoma skin cancers (NMSCs). The use of Imiquimod, a toll‐like‐receptor agonist, is still debated in SOTRs. Objectives The aim of this study
Externí odkaz:
https://doaj.org/article/c46394ebe8ab4b81937f70b3f4ec2533
Autor:
Sara Marchisio, Alessia Andrea Ricci, Gabriele Roccuzzo, Eleonora Bongiovanni, Erika Ortolan, Luca Bertero, Enrico Berrino, Valentina Pala, Renata Ponti, Paolo Fava, Simona Osella-Abate, Silvia Deaglio, Caterina Marchiò, Anna Sapino, Rebecca Senetta, Ada Funaro, Simone Ribero, Pietro Quaglino, Paola Cassoni
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background The introduction of adjuvant therapies for patients with resected cutaneous melanoma (CM) has increased the need for sensitive biomarkers for risk stratification and disease monitoring. This study aims to investigate the utility o
Externí odkaz:
https://doaj.org/article/a50219716124488b83be55f35d8b8a0b
Autor:
Silvia Alberti Violetti, Marco Ardigò, Paolo Fava, Giuseppe Gritti, Erika Morsia, Francesco Onida, Marco Paulli, Alessandro Pileri, Pietro Quaglino, Serena Rupoli, Miriam Teoli, Pamela Vezzoli
Publikováno v:
Drugs in Context, Vol 13, Pp 1-12 (2024)
Topical chlormethine (CL) gel formulation was approved by the EMA in 2017 for the treatment of adult patients with mycosis fungoides (MF). To expand the knowledge on the management of patients with MF, this paper provides an overview of clinical prac
Externí odkaz:
https://doaj.org/article/aed28a1f55c146c2979e660ab38f79d2
Autor:
Pietro Quaglino, Giuseppe Argenziano, Emi Dika, Michela Starace, Simone Amabile, Paolo Fava, Elvira Moscarella, Bianca Maria Piraccini, Alain Delarue, Olivia Dialla, Fabienne Zumaglini, Giampiero Girolomoni
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/4fd6a67e4ae143d39180ed1f713c0bd0
Publikováno v:
Dermatology Reports (2024)
Mycosis Fungoides (MF) is the most common cutaneous T-cell lymphoma that typically presents in the early phase as inflammatory erythematous patches or plaques, with epidermotropism as the histopathological hallmark of the disease. Traditionally, in t
Externí odkaz:
https://doaj.org/article/291e43033a3540b18c47e6e4dcecac78
Autor:
Gabriele Roccuzzo, Nicole Macagno, Cristina Sarda, Jelena Pisano, Simone Ribero, Paolo Fava, Pietro Quaglino
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/55a3c5ca707744b4be8760021a12564a
Autor:
Riccardo Marconcini, Paolo Fava, Amedeo Nuzzo, Simona Manacorda, Marco Ferrari, Francesco De Rosa, Michele De Tursi, Enrica Teresa Tanda, Francesca Consoli, Alessandro Minisini, Nicola Pimpinelli, Francesca Morgese, Melissa Bersanelli, Marco Tucci, Maristella Saponara, Alessandro Parisi, Marcella Ocelli, Serena Bazzurri, Giulia Massaro, Riccardo Morganti, Isabella Ciardetti, Ignazio Stanganelli
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundBRAF and MEK inhibitors target therapies (TT) and AntiPD1 immunotherapies (IT) are available first-line treatments for BRAF v600 mutant metastatic melanoma patients. ECOG PS (E), baseline LDH (L), and baseline number of metastatic sites (N)
Externí odkaz:
https://doaj.org/article/7ed0a33bb9c64531ab12915da799b5dc
Autor:
Gabriele Roccuzzo, Silvia Giordano, Paolo Fava, Alessandro Pileri, Alba Guglielmo, Luca Tonella, Martina Sanlorenzo, Simone Ribero, Maria Teresa Fierro, Pietro Quaglino
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Primary cutaneous T-cell lymphomas (PCTCL) are the most common types of cutaneous lymphomas, with Mycosis fungoides as the most frequent subtype. Besides early stages which usually have a good prognosis, advanced stages remain a great therapeutic cha
Externí odkaz:
https://doaj.org/article/c6cc429395b74facbddb1040776f9414
Publikováno v:
Dermatology Practical & Conceptual, Vol 11, Iss S1 (2021)
The introduction in clinical practice of new drug compounds both targeted therapies anti-BRAF and checkpoint inhibitors have largely improved our potential to manage advanced metastatic melanoma patients. This has led to a significant improvement in
Externí odkaz:
https://doaj.org/article/fc9ee1c4f4f647f099d8873a21b3f64b
Autor:
Alice Ramondetta, Simone Ribero, Luca Conti, Paolo Fava, Elena Marra, Paolo Broganelli, Virginia Caliendo, Franco Picciotto, Michele Guida, Maria Teresa Fierro, Pietro Quaglino
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 1, p adv00001 (2020)
Current therapies for metastatic melanoma (anti-PD1 and BRAF/MEK inhibitors) can cause drug-induced vitiligo. The aim of this study is to dermatologically define and histologically characterize this new type of vitiligo, and assess the clinical cours
Externí odkaz:
https://doaj.org/article/da3957d26258414c80557d7a6327c9c8